BRAF and melanoma: The net effect of these genetic alterations is a shift in the phenotype of BRAF inhibitor-resistant melanoma cells, resulting in an epithelial-to-mesenchymal transition (EMT) [97,98,99], characterized by changes in cell–cell adhesion, cell-matrix adhesion, cellular polarity, and the cytoskeleton [100].